Showing 1 - 6 results of 6 for search 'Shuxian Zhou', query time: 0.03s Refine Results
  1. 1
    Predicting Risk Factors of Acute Kidney Injury in the First 7 Days after Admission: Analysis of a Group of Critically Ill Patients

    Predicting Risk Factors of Acute Kidney Injury in the First 7 Days after Admission: Analysis of a Group of Critically Ill Patients by Kexin Wen, Yongqing Huang, Qi Guo, Tao Wu, Juanzhang Liu, Yuping Zheng, Shuxian Zhou, Dengfeng Geng

    Published 2022-01-01
    Get full text
    Article
  2. 2
    Empagliflozin alleviates atherosclerotic calcification by inhibiting osteogenic differentiation of vascular smooth muscle cells

    Empagliflozin alleviates atherosclerotic calcification by inhibiting osteogenic differentiation of vascular smooth muscle cells by Junping Li, Junping Li, Changping Li, Changping Li, Zhaoqi Huang, Zhaoqi Huang, Chunling Huang, Juanzhang Liu, Juanzhang Liu, Tao Wu, Tao Wu, Shuwan Xu, Peibiao Mai, Dengfeng Geng, Dengfeng Geng, Shuxian Zhou, Shuxian Zhou, Kun Zhang, Kun Zhang, Zhaoyu Liu

    Published 2023-11-01
    Get full text
    Article
  3. 3
    Association of latent class analysis-derived subphenotypes of acute kidney injury with mortality in critically ill patients with cardiovascular disease: a retrospective cohort study

    Association of latent class analysis-derived subphenotypes of acute kidney injury with mortality in critically ill patients with cardiovascular disease: a retrospective cohort stud... by Yongqing Huang, Zhanchao Xiao, Yong Xie, Shaoxin Zheng, Taihui Yu, Zhixuan Guo, Dan Su, Anqi Song, Yangxin Chen, Shuxian Zhou, Qi Guo, Jingfeng Wang

    Published 2022-04-01
    Get full text
    Article
  4. 4
    Sorting nexin 17 increases low-density lipoprotein receptor-related protein 4 membrane expression: A novel mechanism of acetylcholine receptor aggregation in myasthenia gravis

    Sorting nexin 17 increases low-density lipoprotein receptor-related protein 4 membrane expression: A novel mechanism of acetylcholine receptor aggregation in myasthenia gravis by Xiaoxiao He, Xiaoxiao He, Shuxian Zhou, Shuxian Zhou, Ying Ji, Ying Ji, Yingna Zhang, Jie Lv, Shangkun Quan, Jing Zhang, Xue Zhao, Weike Cui, Weike Cui, Wenbo Li, Wenbo Li, Peipei Liu, Peipei Liu, Linyuan Zhang, Linyuan Zhang, Tong Shen, Hua Fang, Junhong Yang, Yunke Zhang, Xinzheng Cui, Qingyong Zhang, Feng Gao

    Published 2022-10-01
    Get full text
    Article
  5. 5
    Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in China

    Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Mu... by Pingjin Gao, Kezhi Mei, Hongwei Li, Qiuyan Dai, Xingui Guo, Daifu Zhang, Zhimin Jin, Hua You, Hong Ding, Ke Lü, Shuxian Zhou, Xiaoling Peng, Hui Xu, Pengfei Yin, Licheng Yu, Lin Pi, Qi Hua, Ming Yang, Xiaowei Yu

    Published 2019-01-01
    Get full text
    Article
  6. 6
    No correlation between acetylcholine receptor antibody concentration and individual clinical symptoms of myasthenia gravis: A systematic retrospective study involving 67 patients

    No correlation between acetylcholine receptor antibody concentration and individual clinical symptoms of myasthenia gravis: A systematic retrospective study involving 67 patients by Lulu Wang, Shumin Wang, Haonan Yang, Jiaojiao Han, Xue Zhao, Sensen Han, Yingna Zhang, Jie Lv, Jing Zhang, Mingqiang Li, Ying Ji, Shuxian Zhou, Xiaoxiao He, Hua Fang, Junhong Yang, Yunke Zhang, Qingyong Zhang, Peiyang Gao, Feng Gao

    Published 2021-07-01
    Get full text
    Article

Search Tools: